Aquaculture UK webinar (June 24, 2021):
Recent years have validated the benefit of genetic improvement of fish stocks in increasing aquaculture productivity – the application of genetic and genomic tools to breeding continues to revolutionize the industry. In this presentation, our CEO, Dr. John Buchanan, explores the types of tools available to companies in the sector and discusses how their application can promote genetic improvement in aquatic species.
Click here to learn more about genomic tools developed at CAT.
Dr. John Buchanan, President and CEO
Prior to helping launch CAT, Dr. Buchanan served for 5 years as the Director of Research and Development at AquaBounty Technologies. Previously, Dr. Buchanan has held a series of research leadership positions at Louisiana State University, the University of California at San Diego School of Medicine, and Kent SeaTech Corporation. Dr. Buchanan has led research on the application of genetic engineering to aquaculture, the use of selective breeding, hatchery technologies, and genomics for improved productivity in finfish, the development of novel therapeutics for aquaculture, and the molecular and genetic basis for virulence in aquatic and human pathogens. He also has experience directing and conducting studies compliant with governmental regulatory standards (GLP/GCP).